Maytansinol is a potent maytansinoid derivative that acts as a microtubule-destabilizing agent, inhibiting tubulin polymerization to induce apoptosis in cancer cells. As a crucial component in the development… Read more
Maytansinol is a potent maytansinoid derivative that acts as a microtubule-destabilizing agent, inhibiting tubulin polymerization to induce apoptosis in cancer cells. As a crucial component in the development of targeted cytotoxic therapies, specifically within the field of antibody-drug conjugates, it is extensively studied in oncology research. This category provides access to Maytansinol reference standards, including stable isotope labelled analogues such as Maytansinol-13C-d3, which are indispensable for analytical testing in pharmaceutical development. Laboratories utilize these high-quality materials for impurity profiling, the identification of metabolites, and the validation of analytical methods during quality control procedures. By providing reliable benchmarks for quantitative analysis, these compounds ensure that the synthesis and formulation of related anticancer agents meet rigorous regulatory and safety specifications throughout the drug development lifecycle.